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A Function of Fas-Associated Death Domain Protein
in Cell Cycle Progression Localized
to a Single Amino Acid at Its C-Terminal Region
(Kuang et al., 2000; Yeh et al., 1998; Zhang et al., 1998).
Its recruitment to the membrane leads to activation of
caspase-8 and subsequent downstream proteases. Mu-
tations in FADD, caspase-8, or FLIP, a caspase-8 activa-
tor/inhibitor that can bind FADD, lead to embryonic le-
Zi Chun Hua,1,2 Sue J. Sohn,1 Chulho Kang,1
Dragana Cado,1 and Astar Winoto1,*
1Department of Molecular and Cell Biology
Division of Immunology and
Cancer Research Laboratory
469 LSA thality (Varfolomeev et al., 1998; Yeh et al., 2000, 1998;
Zhang et al., 1998), suggesting that some of the deathUniversity of California
Berkeley, California 94720 receptors are additionally important for embryonic de-
velopment. Analysis of T cell-specific FADD-knockout2 The State Key Laboratory
of Pharmaceutical Biotechnology and and FADD/→RAG-1/ complementation mice showed
that FADD deficiency in the immune system leads toInstitute of Molecular and Cell Biology
Nanjing University inhibition of the proliferation stage in the CD4CD8(DN)
compartment during thymocyte development. Further-Nanjing 210093
People’s Republic of China more, FADD/ mature T cells fail to proliferate in re-
sponse to anti-CD3/anti-CD28 stimulation (Kabra et al.,
2001; Zhang et al., 1998). Similarly, expression of trans-
genic human FADD dominant-negative proteins inSummary
T cells engenders some of the above FADD deficiency
phenotype (Newton et al., 1998; Walsh et al., 1998; Zor-FADD is an adaptor known to transmit apoptotic sig-
nals from members of the tumor necrosis factor recep- nig et al., 1998), leading to a hypothesis that death do-
main receptors play crucial roles in T cell proliferation.tor family. We show here that FADD has a domain
implicated in cell proliferation. Mice bearing the Asp Although this appears inconsistent with their role in ini-
tiating apoptosis, there are also reports that caspasemutation in the serine 191 phosphorylation site are
runted and anemic and display splenomegaly. Apopto- activation is seen in anti-CD3/CD28-stimulated mature
T cells in the absence of apoptosis and that FasL cansis is unimpaired in these mice, but they exhibit many
immune developmental problems indicative of prolifera- costimulate proliferation and IL-2 production of primary
T cells triggered with suboptimal dose of anti-CD3 anti-tive defects. Mutant FADD T cells are defective in cell
cycle progression, suggesting that regulation of phos- bodies (Alam et al., 1999; Elkon, 1999; Kennedy et al.,
1999). In addition, FLIPL was reported to be capable ofphorylation at serine 191 is essential for growth/prolifer-
ation. Remarkably, serine 191 is conserved among binding to Raf-1 and TRAF1/2 to activate ERK and
NF-B (Kataoka et al., 2000), leading to the suggestionmammalian FADD proteins, but this C-terminal region
is absent in lower organisms, suggesting that FADD that the proliferation defects of FADD null mutation are
due to the inability of death domain receptors to triggeracquired a domain during evolution, rendering it a
“proliferation-apoptosis coupler” that balances cell the FLIPL pathway. Inconsistent with the hypothesis that
death domain receptors regulate proliferation are theproliferation and apoptosis.
observations that Fas deficiency leads to uncontrolled
lymphoproliferation. Most investigators also find thatIntroduction
addition of FasL to mature T cells leads to apoptosis
and not proliferation (Krammer, 2000). FADD/ T cellsMembers of the tumor necrosis factor receptor (TNF-R)
superfamily have been shown to play diverse roles in exhibit disarray of the cell cycle machinery at all phases
of the cell cycle, and human FADD was reported to beapoptosis, growth, and differentiation. A subclass of
these contains a death domain in each of their cyto- phosphorylated specifically in G2/M phases and binds to
a yet-to-be identified G2/M-specific kinase, suggestingplasmic tails that is crucial for transmission of apoptotic
signals. These include Fas, TNF-RI, DR3, DR4/5, and that FADD might directly play a role in the cell cycle
progression (Scaffidi et al., 2000; Zhang et al., 2001).DR6 (Krammer, 2000; Strasser et al., 2000). Fas is crucial
for lymphocyte homeostasis, as its mutation leads to However, the significance of FADD phosphorylation is
not clear. Here, we show that one of the sites of FADDuncontrolled lymphocyte proliferation followed by auto-
immunity, which is exacerbated in Fas/TNF-RI double phosphorylation is the key to its role in the regulation
of growth and proliferation.mutants. Mice with DR6 mutation exhibit enhanced T cell
proliferation (Liu et al., 2001; Zhao et al., 2001), and
mutation at either DR3 or TRAIL, the ligand for DR4/5, Results
results in only minor defects (Cretney et al., 2002; Wang
et al., 2001). These data are consistent with the known Generation of FADD(S191A) and FADD(S191D)
role of death domain-containing receptors in apoptosis. Mutant Mice
FADD (Fas-associated death domain) is a protein con- Human FADD is serine phosphorylated at amino acid
taining a death effector- and a death domain. It mediates 194 (Scaffidi et al., 2000), while mouse FADD is phos-
apoptotic signaling of all the death domain receptors phorylated at both serine and threonine residues (Zhang
and Winoto, 1996). We confirmed that one of the phos-
phorylation sites of mouse FADD is serine 191, an amino*Correspondence: winoto@uclink4.berkeley.edu
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acid that is equivalent to serine 194 of human FADD.
This position is outside the FADD death effector- and
death domains. In Western blot analysis, FADD can be
seen both as a slower-migrating phosphorylated band
and a faster nonphosphorylated species (Zhang and
Winoto, 1996). Transfection of a construct expressing
mutant FADD(S191A) into FADD-deficient fibroblasts
leads to expression of only the faster-migrating FADD
protein (data not shown), suggesting that serine 191
phosphorylation is responsible for the molecular weight
shift detected in Western blot analysis. However, mouse
FADD(S191A) still retains other sites of phosphorylation
which we did not map (Zhang and Winoto, 1996). We
introduced an alanine or an aspartic acid substitution at
the corresponding serine in a FADD genomic construct
(Figure 1A). Previous work has shown that a 12 kb EcoRV
FADD genomic fragment, when introduced as a trans-
gene, is sufficient to reconstitute FADD deficiency and
that this region also contains a locus control region
activity that recapitulates endogenous FADD transcrip-
tion (Kabra et al., 2001). Every transgenic founder of this
fragment expresses FADD in a copy number-dependent
manner. Four transgenic founders were generated for
FADD(S191A) transgene, and two founders were ob-
tained for FADD(S191D). All of them were mated to
FADD/ mice for at least two generations to obtain
mice that express only FADD(S191A) or FADD(S191D)
(with FADD/alleles). These mice are henceforth termed
FADD(S191A) or FADD(S191D) mice, respectively. All
FADD(S191A) mice appear normal. A low percentage
of FADD(S191D) mice are small and die within 4 weeks
of age; the surviving FADD(S191D) mice look normal at
first but become runted with age (see below). Western
blot analysis shows that the majority of phosphorylated
FADD has disappeared in FADD(S191A) mice and, con-
versely, only the slower FADD species are detected in
FADD(S191D) mice (Figure 1A), suggesting that FADD
(S191A) represents the underphosphorylated form of
FADD while FADD(S191D) mimics constitutively serine-
Figure 1. Generation of Mutant Mice with Unphosphorylated and
Constitutively Phosphorylated FADD
(A) Major phosphorylation site of mouse FADD was mapped to serine
191 and changed to either alanine (S191A) or aspartic acid (S191D).
Transgenic mice (Tg) were generated and mated to FADD/ mice
for at least two generations to obtain FADD(S191A) or FADD(S191D)
with FADD/ alleles. Western blot analysis of total splenic lysates
with FADD-specific antibodies was performed to confirm the loss
of upper FADD phosphorylated band (P-FADD) in S191A mice and
the loss of the lower FADD unphosphorylated band (FADD) in S191D
mice.
(B) Fas-initiated apoptosis proceeds normally in FADD(S191D) thy-
mocytes. With the exception of time 0, cycloheximide (CHX) was
added to all samples containing anti-Fas antibody. Samples were
harvested at two different time points (16 or 23 hr), and the percent
apoptotic cells were measured by 7-AAD (7-amino-actinomycin-D)
incorporation.
(C) Fas-initiated apoptosis and AICD proceed normally in
FADD(S191D) spleen cells. Spleen cells are activated with ConA for
2 days, followed by addition of IL-2 and stimulation with either anti-
Fas antibody (upper panel) or anti-CD3 antibody (lower panel). At
two time points (6 or 24 hr later), samples were harvested and the
percent apoptotic cells was measured using 7-AAD. Specific cell
death is calculated by subtracting the percent apoptotic cells cul-
tured in the absence of anti-Fas or anti-CD3 treatment.
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phosphorylated FADD. Both the FADD(S191D) and two also showed abnormalities in these mice. A decrease
of CD19 B cells and an increase of Mac-1 cells canof the FADD(S191A) lines possess low copy numbers
be seen (Figure 2D). A similar phenotype was previouslyof the transgenes (lines D5 and D6 contain two and three
seen in FADD/→RAG-1/ chimeras (Zhang et al.,copies, respectively; lines A12 and A9 contain one and
1998), although the significance of the B cell problemthree copies, respectively) and express mutant FADD
was not appreciated at the time due to the possibilityat roughly equivalent levels to that in the wild-type mice
that embryonic stem cells are intrinsically inefficient at(Figure 1A).
populating the B lineage cells. The decrease in the num-
ber of CD19 cells in FADD(S191D) mice suggests FADDFADD(S191A) and FADD(S191D) Cells Exhibit Normal
functional deficiency leads to defective B cell devel-Receptor-Mediated Apoptosis
opment.To test the ability of mutant FADD to transmit apoptotic
signals, we treated thymocytes from FADD(S191D) or
Aged FADD(S191D) Mice Are Runted and AnemicFADD(S191A) mice with increasing concentrations of
and Exhibit Splenomegalyanti-Fas antibody. The extent of apoptosis is indistin-
When FADD(S191D) mice get older (4–12 months), theyguishable from their FADD/ littermate controls (Figure
look runted in comparison to their FADD/ littermates1B and data not shown). Similar data were obtained
(Figure 3A, left panel). In addition to the immune systemwhen we tested Fas-mediated cell death of ConA-acti-
problems described above, these mice develop spleno-vated splenocytes (Figure 1C). Anti-CD3-mediated acti-
megaly but not lymphadenopathy (Figure 3A, middlevation-induced cell death (AICD) of previously activated
and right panels). We examined their B and T cell popula-mature T cells in the presence of excess IL-2 (Lenardo,
tions to look for B220Thy1T cells, an aberrant popula-1991) is also equivalent between mutant and wild-type
tion of cells that arise in lpr/lpr mice correlating withT cells (Figure 1C). In addition, apoptosis mediated by
T cell autoimmunity (Cohen and Eisenberg, 1991). InS191D or S191A mutant FADD is similar to that of wild-
contrast to aged lpr/lpr strain of mice, no Thy1 B220type protein when they are used to reconstitute FADD-
cells were found in 5- to 12-month-old FADD(S191D)deficient fibroblast cells (data not shown). Thus, muta-
mice (Figure 3B). In addition, the prevalence of CD4tion at the FADD phosphorylation site does not affect
CD8 T cells in lpr/lpr spleen and lymph nodes was notits ability to transmit apoptotic signals in normal cells.
seen in these FADD mutant mice (data not shown). We
conclude that FADD(S191D) mice do not suffer from theDefective Immune System in FADD(S191D) Mice
same autoimmunity as found in the lpr/lpr strain of mice,Thymocytes, splenocytes, lymph nodes, and bone mar-
further confirming the notion that FADD(S191D) canrow cells of 3- to 9-week-old FADD mutant mice were
mediate normal Fas function. Further analysis of theanalyzed for hematopoietic and lymphocyte popula-
FADD(S191D) splenocytes shows an increased numbertions. Thymocyte numbers for FADD(S191D) mice are on
of Gr-1 cells but not NK1.1 cells or cells bearing F4/the average 3-fold less than the wild-type counterparts,
80, a macrophage-specific marker (Figure 3C). Thus, thewhile FADD (S191A) thymi contain normal numbers of
splenomegaly in these mice may simply reflect homeo-cells (Figure 2A and data not shown). Flow cytometric
static expansion of Gr-1 granulocytes due to the low
analysis of CD4 and CD8 expression showed an arrest
numbers of B and T cells.
at the DN to DP (CD4CD8) transition in FADD(S191D)
Analysis of blood from 6- to 10-month-old FADD
but not in FADD(S191A) mice (Figure 2B). The defects (S191D) mice showed decreased counts and percent-
in T cell development in FADD(S191D) mice are seen ages of their red blood cells (RBC) (the average values
in both transgenic lines {FADD(S191D)-5 and FADD for FADD/ and FADD(S191D), respectively, are RBC:
(S191D)-6}, although their severity varies. In the DN pop- 7.39  0.87  106 /mm3 versus 3.91  0.9  106 /mm3 ;
ulation, staining with CD44 and CD25 shows a decrease hematocrit: 42.7  3.76% versus 24.3  2.29%; hemo-
in the DN4 (CD25CD44) and a concomitant increase globin: 14.2  0.8 g/dl versus 7.97  1.61 g/dl). To
of DN3 (CD25CD44) subpopulations (data not shown). determine if erythropoiesis in these mice is abnormal,
This is similar to the observation made in T cell-specific flow cytometric analysis of their bone marrow cells was
FADD knockout mice where loss of FADD leads to an performed. Antibody specific for TER119, a marker for
arrest at the DN3 to DN4 transition (Kabra et al., 2001). erythrocyte lineage cells, shows a significant drop in the
CD25CD4CD8 thymocytes can be divided further RBC population in FADD(S191D) mice (Figure 3D). As
into two subpopulations based on their cell sizes and in the spleen, we found an increase of granulocytes
cell cycle progression, the E subset cells are mostly in (Gr-1) in the FADD(S191D) mutant mice (Figure 3D and
the G1/G0 state whereas the L (larger size) cells are data not shown). This was also seen in FADD/→
mostly in the S/G2/M phases (Hoffman et al., 1996). We RAG-1/ chimeras (our unpublished data). Similar to the
show that FADD(S191D) thymocytes contain fewer L young mice, older FADD(S191D) mice have decreased
cells than the wild-type counterparts (Figure 2C), consis- CD19 (or B220) cell numbers. The block is at the
tent with the notion that proliferation at the DN3 stage transition from CD43 to CD43 stage, suggesting a
is defective in these mice. This early inhibition of T cell defective transition between pro-B and pre-B cell stages
proliferation is further reflected in the fewer mature (Figure 3D, right panel). Overall, these data suggest a
T cells that accumulate in FADD(S191D) peripheral general problem of hematopoiesis resulting from a mu-
lymphoid organs (Figure 2D, left panel). FADD(S191D) tation in the FADD phosphorylation site at serine 191.
mice contain normal spleen cell numbers but slightly The defects in both T and B cell development correlate
fewer lymph node cells (data not shown). Interestingly, with the problems at their respective proliferative
stages.staining for B cell and macrophage/granulocyte markers
Immunity
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Figure 2. Analysis of FADD(S191D) Mice
Mice at 3–9 weeks of age were sacrificed, and their thymocytes, splenocytes, and lymph nodes were analyzed.
(A) Thymocyte number of transgenic Tg FADD(S191D) (both lines 5 and 6) and their FADD/ heterozygous littermates. Bars indicate the
average thymocyte cell number of each genotype (individual animal is denoted as a cross).
(B) Flow cytometric profiles of thymocytes from FADD/ heterozygous littermate, and FADD(S191D) lines 5 and 6 as well as FADD(S191A)
mice are shown. All the FADD Tg mutants are in FADD/ alleles. The total cell number of each thymus is indicated.
(C) Thymocytes from FADD(S191D) were stained with antibodies specific for CD4, CD8, and CD25. Side and forward scatter profiles of DN
thymocytes that express CD25 are shown.
(D) Representative flow cytometric profiles of splenocytes from FADD(S191D) mice and their littermate FADD/ mice were obtained using
anti-CD4 and anti-CD8 (left panel) or anti-CD19 and anti-Mac-1 (right panel) antibodies. Both FADD(S191D) lines display similar phenotypes.
FADD(S191D) T Cells Are Defective as 0, 1, 2, 3, and 4 in Figure 4). In contrast to wild-type
T cells, which undergo at least four cell divisions overin Cell Cycle Progression
To look at the effect of FADD mutation on cell cycle the course of 4 day stimulation, FADD(S191D) T cells
exhibit only one cell division (Figure 4, left and middlemore directly, we used CFSE (Carboxy-Fluorescein-dia-
cetate-Succimidyl Ester) to label resting T cells. Activa- panels). Consistent with these findings, cell cycle analy-
sis with propidium iodide shows significantly fewer cellstion of these cells with anti-CD3 and anti-CD28 antibod-
ies leads to extensive cell proliferation, which can be in S and G2/M phases in the stimulated mutant
FADD(S191D) T cells compared to the controls (Figurevisualized by decreases of CFSE fluorescence (labeled
The Role of FADD Serine 191 in Cell Proliferation
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Figure 3. Characterization of Aged FADD(S191D) Mice
(A) Body weight, spleen weight, and lymph node cell numbers of 4- to 12-month-old FADD(S191D) mice were measured along with their wild-
type littermates. Each cross denotes one animal.
(B) Anti-Thy-1 and B220 staining profiles of spleen cells from aged FADD(S191D) and the wild-type littermates are shown.
(C) Flow cytometric analysis of splenocytes from aged FADD(S191D) mice and their littermate controls.
(D) Flow cytometric analysis of bone marrow cells from FADD(S191D) mice and their littermate controls.
4, right panels). Similar data were also obtained when several other cell cycle proteins in resting FADD/
T cells (Zhang et al., 2001). Expression of a truncatedcells were stimulated with ConA or a combination of
phorbol ester and ionomycin (data not shown). human FADD protein lacking its death-effector domain
(FADD-DN) in T cells was also reported to result in a
cell proliferation problem (Newton et al., 1998; Walsh etDiscussion
al., 1998; Zornig et al., 1998), although there are several
discernible phenotypic differences between the trans-Previous characterization of FADD-deficient T cells indi-
genic mice generated in different groups (possibly duecates that FADD deficiency results in not only apoptotic
to variable expression of FADD-DN). Because FADD-but also proliferative defects. IL-2 signaling is not af-
DN is a powerful dominant-negative protein in blockingfected, but there is a global cell cycle problem at both
the interaction of the endogenous FADD protein to Fasthe G2/M and G1 to S phases (Zhang et al., 1998, 2001).
and TNF-RI death receptors, it was thought that the roleThis correlates with an elevated level of p21 inhibitor
of FADD in proliferation is similarly dependent on itsand reduced levels of cyclin D2/D3 in stimulated
FADD/ T cells as well as constitutive expression of adaptor function. Contrary to this belief, our data show
Immunity
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Figure 4. FADD(S191D) T Cells Are Defective
in Their Proliferative Response to Anti-CD3/
CD28 Stimulation
Cells are stained with CFSE and stimulated
for 4 days with plate-bound anti-CD3/CD28
antibodies. Numbers in the left and middle
panels represent CFSE peaks of undivided
cells (0) and after 1, 2, 3, or 4 rounds of cell
division. Each division results in a 50% de-
crease in the CFSE fluorescence from previ-
ous cell cycle. Right panel: instead of CFSE,
cells are stained with propidium iodide for
DNA content to quantify the percentages of
cells in G2/M and S phases.
that the defects in proliferation can occur in the pres- FADD is also phosphorylated on threonine residues
(Zhang and Winoto, 1996), the residual phosphorylationence of intact FADD death effector- and death domains.
FADD is phosphorylated at serine 194 in human during in FADD(S191A) might be sufficient to allow its dissocia-
tion from X during the G2/M phases, leading to a some-G2/M phases of the cell cycle (Scaffidi et al., 2000) and
at serine 191 (this paper) as well as other unmapped what normal regulation of the protein function. For
FADD-DN, its intact C-terminal region would allow it toresidues in mouse (Zhang and Winoto, 1996). Serine 191
is located outside the domains directly implicated in the bind to protein X but its N-terminal truncation might
result in an inactive FADD-DN/X complex. Furthermore,adaptor function of FADD in apoptosis and as expected,
the Ser191→Asp or Ser191→Ala mutation does not af- overexpression of FADD-DN leads to sequestration of
protein X from the endogenous normal FADD protein,fect its ability to transmit apoptotic signals in vivo and
in vitro. However, mice expressing FADD(S191D) but resulting in inhibition of cell growth. Further biochemical
work to identify the putative interacting protein will benot FADD(S191A) are small and anemic and exhibit many
immunological defects that are remarkably similar to the necessary to validate/refine the model and to see if
FADD(S191D) mutation indeed mimics phosphorylationphenotype associated with the complete loss of FADD
protein. In addition, FADD(S191D) mature T cells are or simply represents a mutation that blocks the function
of the FADD C-terminal region.also defective in T cell receptor-induced cell cycle pro-
gression with problems at the G1 to S transition. These Our work also illustrates the importance of FADD in
mouse physiology where a single amino acid changeresults suggest that serine 191 at the FADD C-terminal
region plays a regulatory role in the FADD proliferative results in dramatic effects in growth and hematopoiesis.
Alignment of FADD proteins from different mammalianfunction and that the roles of FADD in apoptosis and
in proliferation represent two distinct functions utilizing species shows a remarkable conservation of serine 191
and its surrounding amino acids (Figure 5B). Interest-separate domains. Consistent with this notion, the growth
inhibition of human FADD-DN molecule was recently ingly, while the death effector- and death domains are
highly conserved across all species examined, the re-shown to depend on serine 194, an equivalent position
to serine 191 of mouse FADD (M. Peter, personal com- gion containing serine 191 is absent from puffer fish
(Fugu rubripes), mosquito (Anopheles gambriae), and flymunication).
Based on preliminary binding studies of the cellular (Drosophila melanogaster) FADD proteins. Consistent
with the lack of proliferation function for FADD in lowerproteins with various GST-FADD proteins (data not
shown), we propose a hypothetical model to explain the organisms, FADD null Drosophila has no apparent de-
fects except for its inability to clear bacterial infectionstriking similarities of the immune phenotype between
FADD(S191D) and FADD/→RAG-1/ mice, the com- (Hu and Yang, 2000; Leulier et al., 2002; Naitza et al.,
2002). These data suggest that the C-terminal region ofparatively normal phenotype of FADD(S191A) mice, and
the ability of FADD-DN to block cell proliferation. In this the mammalian FADD may represent a domain distinct
from its more conserved (and primitive) apoptotic re-model, the unphosphorylated FADD protein binds to an
intracellular protein (called X for this discussion) and gion, and that this novel domain was acquired during
evolution. Based on the phenomena of cell competitionacquires an activity required for the G1 to S cell cycle
progression (Figure 5A). Phosphorylation of FADD leads and compensation during development whereby “weaker”
cells are actively eliminated through apoptosis, Martinto dissociation of the FADD/X complex. The mutant
FADD(S191D) protein fails to bind protein X at all phases Raff and, more recently, John Abrams have hypothe-
sized for the existence of a class of molecules that linksof the cell cycle, leading to an inactive X protein and
subsequent failure of the cell cycle progression. In con- proliferation and apoptosis (Abrams, 2002; Raff, 1992).
These “proliferation-apoptosis couplers” coordinate thetrast, the FADD(S191A) mutant protein, at its unphos-
phorylated state, can still bind to protein X. As mouse balance between cell proliferation and cell death. Our
The Role of FADD Serine 191 in Cell Proliferation
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Figure 5. A Model and the C-Terminal Sequences of FADD in Cell Cycle Regulation
(A) A model of FADD-mediated cell cycle regulation.
(B) Alignment of FADD proteins from seven different species. Shaded boxes indicate conserved amino acids. Only the C-terminal regions are
shown to highlight the conservation of serine 191 (arrow) in mammals.
fragments were generated using primers 1 and 2 or 3 and 4. Primersstudy indicates that FADD may belong to this class of
2 and 3 are complementary to each other and contain the corre-proteins. Deletion of the FADD gene leads to protection
sponding mutation. For FADD(S191D) mutant, primer 2 is GAATCCfrom cell death (Zhang et al., 1998) and also loss of
CTTAGTACGGGGTCCATATTCTCACTC, while for FADD S191A,
proliferative function. We have now identified a domain primer 2 is GAATCCCTTAGTACGGGGGCCATATTCTCACTC. The
in FADD that regulates cell proliferation independent changes are TCC (serine) to GAC (Asp) or GCC (Ala) and a base
pair silent mutation AGTACT to CGTACT to abolish the ScaI site.of its role in receptor-mediated cell death. This further
The two PCR products were then mixed together and re-amplifiedstrengthens the notion that FADD directly controls both
using primers 1 (GATTTACCCATGGACCCATTC) and 4 (AGACCACcell proliferation and cell death. Future work is neces-
CATGGAGGCAAGG) to yield a 2.5 kb product. After XhoI and NcoI
sary to dissect its exact molecular role in cell cycle digestion, the 1.6 kb fragment was cloned into MortE4.7 plasmid,
progression and how FADD balances the process of which contains a 4.7 kb EcoRI FADD genomic fragment in pSP72
apoptosis and cell proliferation. (Kabra et al., 2001). The resulting constructs were verified by se-
quencing for the lack of any other changes. For transgene con-
Experimental Procedures structs, the mutant clones were first digested with XhoI and EcoRI.
The corresponding 3.3 kb insert was mixed with a 8.8 kb EcoRV/
Plasmids partial XhoI wild-type fragment and ligated to the EcoRI-EcoRV
Mutagenesis was carried out by several rounds of PCR amplifica- plasmid fragment of p318 in a three-way ligation reaction (note:
p318 contains a 12.2kb EcoRV wild-type fragment of FADD gene intions. First, using the FADD genomic clone as a template, two PCR
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